After three years of doing the same for COVID-19 - repeatedly questioning the evidence for masking, risk-benefit calculus of COVID vaccines for young men and general competence of American regulators relative to European counterparts - the University of California San Francisco epidemiologist is facing his greatest cancellation risk yet.